Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 1 of 52 PageID #: 1352
`Case 1:15-cv—00697-RGA Document 99-2 Filed 08/14/17 Page 1 of 52 PageID #: 1352
`
`EXHIBIT G
`
`EXHIBIT G
`PUBLIC VERSION
`
`PUBLIC VERSION
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 2 of 52 PageID #: 1353
`
`EXHIBIT G
`
`Amneal’s Exhibit List with Hospira’s Objections Thereto
`
`Pursuant to Local Rule 16.3(c)(6), Amneal provides its list of trial exhibits below.
`
`Amneal reserves the right to amend this list at any time, in accordance with the terms of the
`
`Pretrial Order or as otherwise permitted. Amneal reserves the right to introduce summary
`
`exhibits in accordance with FRE 1006.
`
`[See accompanying spreadsheet]
`
`1
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 3 of 52 PageID #: 1354
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`DTX
`
`PTX
`
`JTX
`
`description
`
`date
`
`DTX001 PTX141 JTX092
`
`DTX002
`
`DTX003
`
`DTX004
`
`DTX005
`
`DTX006
`
`Amneal's ANDA (DEX 1-4827)
`
`Berkenbosch, J., et al, Prospective
`evaluation of dexmedetomidine for
`noninvasive procedural sedation in
`children, Pediatric Critical Care
`Medicine, Vol. 6, No. 4, 435-439 (2005)
`
`Cain, J., Dexmedetomidine and
`Hextend: Their Role in Trauma Care,
`International TraumaCare, Vol 17, No.
`1, 4-5 (2007)
`
`Cain Rebuttal Expert Report On Non-
`Infringement
`Callahan, P., et al., Dexmedetomidine
`for Infant Pulmonary Function Testing,
`Pediatric Pulmonology, Vol. 50, 150-
`154 (2015)
`
`Cheung, C., et al., Analgesic and
`sedative effects of intranasal
`dexmedetomidine in third molar surgery
`under local anaesthesia, British Journal
`of Anaesthesia, Vol. 3, 430-437 (2011)
`
`source
`Ramsay Reply MC; Ramsay Opening
`Exs.; Linhardt Reply MC; Linhardt
`Opening Exs.; Hofmann Reply MC;
`Cain Rebuttal MC; Bloch Rebuttal
`MC
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`DEX 000001 [4827]
`
`1/1/2005 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146043
`[146047]
`
`Au, F, H, P, R
`
`1/1/2007
`
`Ramsay Reply MC; Ramsay Rebuttal
`MC; Linhardt Rebuttal MC; Yaman
`Opening MC; Cain Reply MC; Cain
`Opening MC; Cain Rebuttal MC
`3/20/2017 Ramsay Reply MC; Yaman Reply
`MC
`
`DEX 063183
`[63184]
`
`F, H, P, R
`
`1/1/2015 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146015
`[146019]
`
`F, H, P, R, U
`
`Au, F, H, P, R
`
`1/1/2011
`
`Ramsay Reply MC; Ramsay Rebuttal
`MC; Cain Opening MC; Cain
`Rebuttal MC
`
`DEX 145664
`[145671]
`
`Au, F, H, P, R
`
`Claim Construction Order: Hospira Inc.
`v. Amneal Pharmaceuticals LLC, C.A.
`No. 15-697-RGA, D.I. 57 (D. Del. May
`25, 2016)
`
`5/25/2016
`
`Ramsay Reply MC; Ramsay Rebuttal
`MC; Yaman Opening MC; Cain
`Opening MC; Ramsay Opening Exs.;
`Linhardt Reply MC; Linhardt
`Opening Exs.; Cain Rebuttal MC;
`Bloch Rebuttal MC
`
`DTX007 PTX130 JTX082
`
`H, P, R, U
`
`Page 1 of 50
`
`

`

`DTX
`
`PTX
`
`JTX
`
`DTX008
`
`DTX009
`
`DTX010
`
`DTX011
`
`DTX012
`
`DTX013
`
`DTX014
`
`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 4 of 52 PageID #: 1355
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`description
`Dinesh, G., et al., Dexmedetomidine: An
`Ideal Drug for Procedural Sedation
`Outside Operation Theatre, Journal of
`Evolution of Medical and Dental
`Sciences, Vol. 4, No. 21, 37153723
`(March, 2015)
`Ghai, B., et al., Effect of Low Dose
`Dexmedetomidine on Emergence
`Delirium and Recovery Profile
`following Sevoflurance Induction in
`Pediatric Cataract Surgeries, Journal of
`Anesthesiology, Vol. 2015, Article ID
`617074 (2015)
`Hasanin, A., et al., Dexmedetomidine
`versus propofol for sedation during
`gastrointestinal endoscopy in pediatric
`patients, Egyptian Journal of
`Anaesthesia, Vol. 30, 21-26 (2014)
`
`date
`
`source
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`1/1/2015 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146034
`[146042]
`
`Au, F, H, P, R
`
`1/1/2015 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146056
`[146062]
`
`Au, F, H, P, R
`
`1/1/2014 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146064
`[146069]
`
`Au, F, H, P, R
`
`Precedex 2012 Label
`
`9/26/2012 Ramsay Reply MC
`
`Precedex Prescribing Information
`
`9/1/2012 Ramsay Reply MC
`
`HOSPIRA 0001194
`[1195]
`HOSPIRA 0001212
`[1228]
`
`X
`
`X
`
`H, P, R, U
`
`9/28/2016
`
`Ramsay Reply MC; Ramsay Opening
`Exs.; Linhardt Reply MC; Linhardt
`Opening Exs.; Cain Rebuttal MC;
`Bloch Rebuttal MC
`
`Hospira’s Supplemental Infringement
`Contentions: Hospira Inc. v. Amneal
`Pharmaceuticals LLC, C.A. No. 15-697-
`RGA (D. Del. Sept. 28, 2016)
`Jamaliya, R., et al., The efficacy and
`hemodynamic response to
`Dexmedetomidine as a hypotensive
`agent in posterior fixation surgery
`following traumatic spine injury, Journal
`of Anaesthesiology Clinical
`Pharmacology, Vol. 30, No. 2, 203-207
`(April-June, 2014)
`
`1/1/2016 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 145998
`[146002]
`
`Au, F, H, P, R
`
`Page 2 of 50
`
`

`

`DTX
`
`PTX
`
`JTX
`
`DTX015
`
`DTX016
`
`DTX017
`
`DTX018
`
`DTX019
`
`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 5 of 52 PageID #: 1356
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`description
`Jewitt, J., et al., Dexmedetomidine for
`procedural sedation in the emergency
`department, European Journal of
`Emergency Medicine, Vol. 17, No. 1, 60
`(2010) [excerpt]
`
`Jones, J., et al., Evaluation of
`Dexmedetomidine and Postoperative
`Pain Management in Patients with
`Adolescent Idiopathic Scoliosis:
`Conclusions Based on a Retrospective
`Study at a Tertiary Pediatric Hospital,
`Pediatric Critical Care Medicine, Vol.
`15, No. 6, 247-252 (2014)
`
`Kol, I., et al., Controlled Hypotension
`with Desflurane Combined with
`Esmolol or Dexmedetomidine During
`Tympanoplasty in Adults: A Double-
`Blind, Randomized, Controlled Trial,
`Current
`
`Koroglu, A., et al., A Comparison of the
`Sedative, Hemodynamic, and
`Respiratory Effects of
`Dexmedetomidine and Propofol in
`Children Undergoing Magnetic
`Resonance Imaging, Anesthesia &
`Analgesia, Vol. 103, No. 1, 63-67 (2006)
`
`Lee, S., et al., Comparison of
`dexmedetomidine with on-demand
`midazolam versus midazolam alone for
`procedural sedation during endoscopic
`submucosal dissection of gastric tumor,
`Journal of Digestive Diseases, No. 16,
`377-384 (2015)
`
`date
`
`source
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`1/1/2010 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146100
`
`Au, F, H, P, R
`
`1/1/2014 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146089
`[146094]
`
`Au, F, H, P, R
`
`1/1/2009 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146003
`[146014]
`
`Au, F, H, P, R
`
`1/1/2015 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146070
`[146074]
`
`Au, F, H, P, R
`
`1/1/2015 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146020
`[146027]
`
`Au, F, H, P, R
`
`Page 3 of 50
`
`

`

`DTX
`
`PTX
`
`JTX
`
`DTX020
`
`DTX021
`
`DTX022
`
`DTX023
`
`DTX024
`
`DTX025
`
`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 6 of 52 PageID #: 1357
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`description
`Liu, Y., et al., Consequences of
`dexmedetomidine on emergence
`delirium following sevoflurance
`anesthesia in children with cerebral
`palsy, International Journal of Clinical
`and Experimental Medicine, Vol. 8, No.
`9, 16238-16244 (2015)
`Mason, K., et al., Incidence and
`predictors of hypertension during high-
`dose dexmedetomidine sedation for
`pediatric MRI, Pediatric Anesthesia,
`Vol. 20, 516-523 (2010)
`
`McMorrow, S., et al., Dexmedetomidine
`Sedation Uses in Pediatric Procedural
`Sedation Outside the Operating Room,
`Pediatric Emergency Care, Vol. 28, No.
`3, 292-296 (2012)
`
`date
`
`source
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`1/1/2015 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146075
`[146081]
`
`Au, F, H, P, R
`
`1/1/2010 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 145958
`[145965]
`
`Au, F, H, P, R
`
`1/1/2012 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146095
`[146099]
`
`Au, F, H, P, R
`
`Hospira’s Precedex® Label (2010)
`(DEX 5014-5033)
`
`1/1/2010
`
`Ramsay, M., et al., Dexmedetomidine as
`a total intravenous anesthetic agent,
`Anesthesiology, Vol. 101, No. 3, 787-
`790 (2004)
`
`Shukry, M., et al., Does
`dexmedetomidine prevent emergence
`delirium in children after sevoflurane-
`based general anesthesia?, Pediatric
`Anesthesia, Vol. 15, 1098-1104 (2005)
`
`Ramsay Reply MC; Ramsay Rebuttal
`MC; Linhardt Rebuttal MC; Yaman
`Reply MC; Yaman Opening MC;
`Cain Reply MC; Cain Opening MC;
`Cain Rebuttal MC; Ramsay Depo Ex.
`16
`Ramsay Reply MC; Ramsay Rebuttal
`MC; Cain Reply MC; Cain Opening
`MC; Cain Rebuttal MC; Ramsay
`Depo Ex. 21
`
`DEX 005014 [5033] X
`
`DEX 145725
`[145733]
`
`F, H, P, R
`
`1/1/2004
`
`1/1/2005 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 145966
`[145972]
`
`Au, F, H, P, R
`
`Page 4 of 50
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 7 of 52 PageID #: 1358
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`DTX
`
`PTX
`
`JTX
`
`DTX026
`
`DTX027
`
`description
`Song, J., et al., The Opioid-sparing
`Effect of Intraoperative
`Dexmedetomidine Infusion After
`Craniotomy, Journal of Neurosurgical
`Anesthesiology, Vol. 28, No. 1, 14-20
`(2015)
`
`Techanivate, A., et al., A Comparison of
`Dexmedetomidine versus Propofol on
`Hypotension during Colonoscopy under
`Sedation, Journal of Anesthesia and
`Clinical Research, Vol. 3, No. 11 (2012)
`
`U.S. Patent No. 8,242,158
`(Roychowdhury)
`
`date
`
`source
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`1/1/2015 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146082
`[146088]
`
`Au, F, H, P, R
`
`1/1/2012 Ramsay Reply MC; Cain Rebuttal
`MC
`
`DEX 146028
`[146033]
`
`Au, F, H, P, R
`
`Ramsay Reply MC; Ramsay Rebuttal
`MC; Ramsay Opening Exs.; Linhardt
`Reply MC; Linhardt Opening Exs.;
`Gerardi Rebuttal MC; Yaman Reply
`MC; Yaman Opening MC; Hofmann
`Reply MC; Cain Reply MC; Cain
`Opening MC; Cain Rebuttal MC;
`Bloch Rebuttal MC
`
`DEX 007234 [7247]
`
`DTX028 PTX001 JTX001
`
`DTX029
`
`Cain Rebuttal Expert Report On Non-
`Infringement Materials Considered
`(MC)
`
`3/20/2017
`
`Cain Rebuttal MC
`
`F, H, P, R, U
`
`U.S. Patent No. 8,338,470
`(Roychowdhury)
`
`DTX030 PTX002 JTX002
`
`Ramsay Reply MC; Ramsay Rebuttal
`MC; Ramsay Opening Exs.; Linhardt
`Reply MC; Linhardt Opening Exs.;
`Gerardi Rebuttal MC; Yaman Reply
`MC; Yaman Opening MC; Hofmann
`Reply MC; Cain Reply MC; Cain
`Opening MC; Cain Rebuttal MC;
`Bloch Rebuttal MC
`
`DEX 007638 [7651]
`
`Page 5 of 50
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 8 of 52 PageID #: 1359
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`DTX
`
`PTX
`
`JTX
`
`description
`
`date
`
`source
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`U.S. Patent No. 8,455,527
`(Roychowdhury)
`
`U.S. Patent No. 8,648,106
`(Roychowdhury)
`
`DTX031 PTX003 JTX003
`
`DTX032 PTX004 JTX004
`
`Yaman Opening Expert Report On
`Patent Invalidity
`
`2/17/2017
`
`Ramsay Reply MC; Ramsay Rebuttal
`MC; Ramsay Opening Exs.; Linhardt
`Reply MC; Linhardt Opening Exs.;
`Gerardi Rebuttal MC; Yaman Reply
`MC; Yaman Opening MC; Hofmann
`Reply MC; Cain Reply MC; Cain
`Opening MC; Cain Rebuttal MC;
`Bloch Rebuttal MC; Ramsay Depo
`Ex. 18
`
`Ramsay Reply MC; Ramsay Rebuttal
`MC; Ramsay Opening Exs.; Linhardt
`Reply MC; Linhardt Opening Exs.;
`Gerardi Rebuttal MC; Yaman Reply
`MC; Yaman Opening MC; Hofmann
`Reply MC; Cain Reply MC; Cain
`Opening MC; Cain Rebuttal MC;
`Linhardt Depo Ex. 1; Bloch Rebuttal
`MC; Ramsay Depo Ex. 8
`
`Ramsay Rebuttal MC; Gerardi
`Rebuttal MC; Yaman Reply MC;
`Cain Reply MC; Cain Opening MC;
`Linhardt Reply MC
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Reply MC;
`Yaman Opening MC; Cain Reply
`MC; Cain Opening MC; Linhardt
`Rebuttal MC
`
`DEX 007990 [8003]
`
`DEX 008336 [8350]
`
`F, H, P, R, U
`
`DEX 145421
`[145423]
`
`Au, F, H, P, R
`
`DTX033
`
`DTX034
`
`DTX035
`
`1/1/2012
`
`Anderson, C., et al., Stability of
`dexmedetomidine 4 µg/mL in
`polypropylene syringes, Am. J. Health-
`Syst. Pharm, Vol. 69, 595-97 (2012)
`
`Anttila, M., et al., Bioavailability of
`dexmedetomidine after extravascular
`doses in healthy subjects, British Journal
`of Pharmacology, Vol. 56, 691-698
`(2003)
`
`1/1/2003 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145661
`[145663]
`
`Au, F, H, P, R
`
`Page 6 of 50
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 9 of 52 PageID #: 1360
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`DTX
`
`PTX
`
`JTX
`
`description
`
`date
`
`source
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`DTX036
`
`DTX037
`
`DTX038
`
`DTX039 PTX069 JTX045
`
`DTX040
`
`DTX041
`
`Cain Opening Expert Report On
`Invalidity
`
`Fresenius's Notice of Deposition of
`Cedergren
`Canadian Society of Hospital
`Pharmacists (CSHP), Guidelines for
`DrugUse Control, (2008)
`
`DiSilvio, G., et al. Intranasal
`Dexmedetomidine & Midazolam: A
`Novel Sedation Technique for Infant
`PFT, Abstract accepted by the Society
`for Pediatric Anesthesiology with poster
`presented at Annual Spring Meeting,
`Phoenix, AZ (March 2015)
`
`Dogru, K., et al., The Effectiveness of
`Intramuscular Dexmedetomidine on
`Hemodynamic Responses During
`Tracheal Intubation and Anesthesia
`Induction of Hypertensive Patients: A
`Randomized, Double-Blind, Placebo-
`Controlled Study, Current Therapeutic
`Research, Vol. 68, No. 5 (Sep.-Oct.
`2007)
`
`2/17/2017
`
`9/29/2016
`
`1/1/2008
`
`Ramsay Rebuttal MC; Yaman
`Opening MC; Ramsay Reply MC;
`Gerardi Rebuttal MC; Cain Reply MC
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Opening MC;
`Cain Opening MC
`
`DEX 063185
`[63213]
`
`F, H, P, R, U
`
`F, H, P, R, U
`
`Au, F, H, P, R
`
`1/1/2015 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145507
`[145510]
`
`Au, F, H, P, R
`
`1/1/2007 Ramsay Rebuttal MC; Cain Reply
`MC; Cain Opening MC
`
`DEX 145672
`[145682]
`
`Au, F, H, P, R
`
`Dosing Guidelines for Precedex (2009)
`(DEX 8624-8638)
`
`1/1/2009
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Opening MC;
`Cain Opening MC
`
`DEX 008624 [8638] P, R
`
`Page 7 of 50
`
`

`

`DTX
`
`PTX
`
`JTX
`
`DTX042
`
`DTX043
`
`DTX044
`
`DTX045
`
`DTX046
`
`DTX047
`
`DTX048
`
`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 10 of 52 PageID #: 1361
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`description
`Dyck, J.D., et al., The Pharmacokinetics
`and Hemodynamic Effects of
`Intravenous and Intramuscular
`Dexmedetomidine Hydrochloride in
`Adult Human Volunteers,
`Anesthesiology, Vol. 78, No. 5, 813-820
`(1993)
`
`Eichhorn, J., APSF Hosts Medication
`Safety Conference, APSF Newsletter,
`Vol. 25, No. 1, 1-20 (2010)
`
`Fanikos, J., Premixed Products Improve
`Safe Medication Practices, Pharmacy
`Practice News, 56-57 (November 2011)
`
`Gerlach, A., et al., A new dosing
`protocol reduces dexmedetomidine-
`associated hypotension in critically ill
`surgical patients, Journal of Critical
`Care, Vol. 24, No. 4, 568-574 (2009)
`Giorgi, I., et al., Risk and
`pharmacoeconomic analyses of the
`injectable medication process in the
`paediatric and neonatal intensive care
`units, International Journal for Quality
`in Health Care, Vol. 22, No. 3, 170-178
`(2010)
`Iirola, T., et al., Bioavailability of
`dexmedetomidine after intranasal
`administration, European Journal of
`Clinical Pharmacology, Vol. 67, No. 8,
`825-831 (2011)
`IPR2016-01577 - Decision granting
`Institution of IPR (DEX 145877-
`145892)
`
`date
`
`source
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`1/1/1993
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Opening MC;
`Cain Reply MC; Cain Opening MC
`
`DEX 145511
`[145518]
`[replacement
`images]
`
`Au, F, H, P, R
`
`1/1/2010
`
`1/1/2011
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Reply MC;
`Yaman Opening MC; Cain Reply
`MC; Cain Opening MC
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Reply MC;
`Yaman Opening MC; Cain Opening
`MC
`
`1/1/2009
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Reply MC;
`Yaman Opening MC; Cain Reply
`MC; Cain Opening MC
`
`1/1/2010
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Reply MC;
`Yaman Opening MC; Cain Reply
`MC; Cain Opening MC; Ramsay
`Depo Ex. 7
`
`DEX 004839 [4858] Au, F, H, P, R
`
`DEX 004859 [4860] Au, F, H, P, R
`
`DEX 004885 [4897] Au, F, H, P, R
`
`DEX 004898 [4906] Au, F, H, P, R
`
`1/1/2011 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145683
`[145689]
`
`Au, F, H, P, R
`
`2/9/2017 Ramsay Rebuttal MC; Yaman
`Opening MC; Cain Opening MC
`
`DEX 145877
`[145892]
`
`P, R
`
`Page 8 of 50
`
`

`

`DTX
`
`PTX
`
`JTX
`
`DTX049
`
`DTX050
`
`DTX051
`
`DTX052
`
`DTX053
`
`DTX054
`
`DTX055
`
`DTX056
`
`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 11 of 52 PageID #: 1362
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`description
`IPR2016-01578 - Decision granting
`Institution of IPR (DEX 145893-
`145911)
`IPR2016-01579 - Decision granting
`Institution of IPR (DEX 145912-
`145930)
`IPR2016-01580 - Decision denying
`Institution of IPR (DEX 145803-
`145813)
`
`Jayaraman, L., et al., A comparative
`study to evaluate the effect of intranasal
`dexmedetomidine versus oral
`alprazolam as a premedication agent in
`morbidly obese patients undergoing
`bariatric surgery, Journal of
`Anaesthesiology Clinical Pharmacology,
`Vol. 29, No. 2, 179-182 (2013)
`
`Jordan, V., et al., Dexmedetomidine
`overdose in the perioperative setting,
`The Annals of Pharmacotherapy, Vol.
`38, No. 5, 803-807 (2004)
`
`Lavoisier Sodium Chloride 0.9%
`injectable solution
`
`Li, B., et al., Intranasal
`dexmedetomidine following failed
`chloral hydrate sedation in children,
`Anaesthesia, Vol. 69, No. 3, 240-244,
`(2014)
`
`date
`source
`2/9/2017 Ramsay Rebuttal MC; Yaman
`Opening MC; Cain Opening MC
`
`2/9/2017
`
`Ramsay Rebuttal MC; Yaman Reply
`MC; Yaman Opening MC; Cain
`Opening MC
`2/3/2017 Ramsay Rebuttal MC; Yaman
`Opening MC; Cain Opening MC
`
`begBates
`[endBates]
`
`DEX 145893
`[145911]
`
`DEX 145912
`[145930]
`
`DEX 145803
`[145813]
`
`Hospira's
`Objections
`
`P, R
`
`P, R
`
`P, R
`
`1/1/2013 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145690
`[145693]
`
`Au, F, H, P, R
`
`1/1/2004 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145694
`[145698]
`
`Au, F, H, P, R
`
`1/1/2009
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Opening MC;
`Cain Opening MC
`
`DEX 008639 [8642]
`[replacement
`images]
`
`Au, F, H, P, R
`
`1/1/2014 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145699
`[145703]
`
`Au, F, H, P, R
`
`Linhardt Rebuttal Expert Report
`
`3/20/2017
`
`Ramsay Rebuttal MC; Gerardi
`Rebuttal MC; Yaman Reply MC;
`Hofmann Reply MC; Cain Reply MC;
`Linhardt Depo Ex. 3
`
`F, H, P, R, U
`
`Page 9 of 50
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 12 of 52 PageID #: 1363
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`DTX
`
`PTX
`
`JTX
`
`description
`
`date
`
`source
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`Martin, E., et al., The role of the alpha2-
`adrenoceptor agonist dexmedetomidine
`in postsurgical sedation in the intensive
`care unit, Journal of Intensive Care
`Medicine, Vol. 18, No. 1, 29-41 (2003)
`
`Mason, K., et al., Intramuscular
`Dexmedetomidine: An Effective Route
`of Sedation Preserves Background
`Activity for Pediatric
`Electroencephalograms, Journal of
`Pediatrics, Vol. 161, No. 5, 927-932e2
`(2012)
`Mason, K., et al., Intramuscular
`Dexmedetomidine Sedation for Pediatric
`MRI and CT, American Journal of
`Roentgenology, Vol. 197, 720-725
`(2011)
`Max, B., et al., Extended infusion of
`dexmedetomidine to an infant at sixty
`times the intended rate, International
`Journal of Pediatrics, Vol. 2010
`
`Merry, A., et al., Medication errors -
`new approaches to prevention, Pediatric
`Anesthesia, Vol. 21, 743-753 (2011)
`
`Neu, J., et al., Calculator assisted
`determination of dilutions for
`continuous infusion ICU medications,
`Critical Care Medicine, Vol. 10, No. 9,
`610-612 (1982)
`
`1/1/2003 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145531
`[145543]
`
`Au, F, H, P, R
`
`1/1/2012 Ramsay Rebuttal MC; Cain Reply
`MC; Cain Opening MC
`
`DEX 145710
`[145717]
`
`Au, F, H, P, R
`
`1/1/2011 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145704
`[145709]
`
`Au, F, H, P, R
`
`1/1/2010 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145718
`[145724]
`
`Au, F, H, P, R
`
`1/1/2011 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145544
`[145554]
`
`Au, F, H, P, R
`
`1/1/1982 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145555
`[145557]
`
`Au, F, H, P, R
`
`DTX057
`
`DTX058
`
`DTX059
`
`DTX060
`
`DTX061
`
`DTX062
`
`Page 10 of 50
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 13 of 52 PageID #: 1364
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`DTX
`
`PTX
`
`JTX
`
`description
`
`date
`
`source
`
`Palmgrén, J., et al., Drug adsorption to
`plastic containers and retention of drugs
`in cultured cells under in vitro
`conditions, European Journal of
`Pharmaceutics and Biopharmaceutics,
`Vol. 64, 369-378 (2006)
`
`Potts, A., et al., Computerized Physician
`Order Entry and Medication Errors in a
`Pediatric Critical Care Unit, Pediatrics,
`Vol. 113, No. 1, 5963 (2004)
`
`Reynolds, J., et al., A prospective,
`randomized, double-blind trial of
`intranasal dexmedetomidine and oral
`chloral hydrate for sedated auditory
`brainstem response (ABR) testing,
`Pediatric Anesthesia, Vol. 26, No. 3, 286-
`293 (2016)
`Rodriguez-Gonzalez, C., et al.,
`Prevalence of medication administration
`errors in two medical units with
`automated prescription and dispensing,
`Journal of American Medical
`Information Association, Vol. 19, 72-78
`(2011)
`Rosen, D., et al., Short duration large
`dose dexmedetomidine in a pediatric
`patient during procedural sedation,
`Anesthesia & Analgesia, Vol. 103, No.
`1, 68-69 (2006)
`
`DTX063
`
`DTX064
`
`DTX065
`
`DTX066
`
`DTX067
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`DEX 004915 [4924] Au, F, H, P, R
`
`1/1/2006
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Reply MC;
`Yaman Opening MC; Cain Reply
`MC; Cain Opening MC; Ramsay
`Depo Ex. 14
`
`1/1/2004 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145566
`[145572]
`
`Au, F, H, P, R
`
`1/1/2016 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145734
`[145741]
`
`Au, F, H, P, R
`
`1/1/2011 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145573
`[145579]
`
`Au, F, H, P, R
`
`1/1/2006 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145757
`[145758]
`
`Au, F, H, P, R
`
`Page 11 of 50
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 14 of 52 PageID #: 1365
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`DTX
`
`PTX
`
`JTX
`
`description
`
`date
`
`source
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`DTX068
`
`DTX069
`
`DTX070
`
`DTX071
`
`DTX072
`
`DTX073
`
`DTX074
`
`Scheinin, H., et al., Intramuscular
`Dexmedetomidine as Premedication for
`General Anesthesia, Anesthesiology,
`Vol. 78, 1065-1075 (1993)
`
`Stanaszek, W., et al., Comparison of
`Drug Stability in Glass Versus Plastic
`Containers: Analysis of Prefilled
`Syringe Admixtures, Pro. Okla. Acad.
`Sci., Vol. 58, 102-105 (1978)
`Talon, MD, et al., Intranasal
`dexmedetomidine premedication is
`comparable with midazolam in burn
`children undergoing reconstructive
`surgery, Journal of Burn Care &
`Research, Vol. 30, No. 4, 599-605
`(2009)
`Tobias, J., Dexmedetomidine:
`Applications in pediatric critical care
`and pediatric anesthesiology, Pediatr.
`Crit. Care Med., Vol. 8, No. 2, 115-131
`(2007)
`
`U.S. Patent No. 4,544,664 (Karjalainen)
`
`U.S. Patent No. 4,910,214 (Karjalainen)
`
`U.S. Patent No. 6,716,867 (Aantaa)
`
`1/1/1993
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Opening MC;
`Cain Reply MC; Cain Opening MC
`
`DEX 145580
`[145590]
`
`Au, F, H, P, R
`
`1/1/1978
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Reply MC;
`Yaman Opening MC; Cain Opening
`MC
`
`DEX 063214
`[63217]
`
`Au, F, H, P, R
`
`1/1/2009 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145760
`[145766]
`
`Au, F, H, P, R
`
`1/1/2007 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145591
`[145607]
`
`Au, F, H, P, R
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Opening MC;
`Cain Opening MC
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Opening MC;
`Hofmann Reply MC; Cain Opening
`MC
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Opening MC;
`Hofmann Reply MC; Cain Opening
`MC
`
`DEX 006670 [6683] Au, F, H, P, R
`
`DEX 006688 [6691] Au, F, H, P, R
`
`DEX 006899 [6909] Au, F, H, P, R
`
`Page 12 of 50
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 15 of 52 PageID #: 1366
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`DTX
`
`PTX
`
`JTX
`
`description
`
`date
`
`DTX075
`
`DTX076
`
`DTX077
`
`DTX078 PTX128 JTX081
`
`DTX079
`
`DTX080
`
`File history of U.S. Patent No. 8,338,470
`(US 13/541,524)
`
`Venn, R.M., et al., Preliminary UK
`experience of dexmedetomidine, a novel
`agent for postoperative sedation in the
`intensive care unit, Anaesthesia, Vol. 54,
`1136-1142 (1999)
`
`WHO Collaborating Centre for
`Pharmaceutical Pricing and
`Reimbursement Policies, Glossary of
`Preferred Terms – Injectable, available
`at
`http://whocc.goeg.at/Glossary/Preferred
`Terms
`Yuen, V., et al., A comparison of
`intranasal dexmedetomidine and oral
`midazolam for premedication in
`pediatric anesthesia: a double-blinded
`randomized controlled trial, Vol. 106,
`No. 6, 1715-1721 (2008)
`Yuen, V., et al., A Double-Blind,
`Crossover Assessment of the Sedative
`and Analgesic Effects of Intranasal
`Dexmedetomidine, Anesthesia &
`Analgesia, Vol. 105, No. 2, 374-380
`(2007)
`Yuen, V., et al., Optimal timing for the
`administration of intranasal
`dexmedetomidine for premedication in
`children, Anaesthesia, Vol. 65, 922-929
`(2010)
`
`source
`Ramsay Rebuttal MC; Yaman
`Opening MC; Cain Opening MC;
`Ramsay Depo Ex. 9
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`DEX 007248 [7637]
`
`1/1/1999
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Opening MC;
`Cain Opening MC
`
`DEX 145619
`[145625]
`
`Au, F, H, P, R
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Reply MC;
`Yaman Opening MC; Cain Reply
`MC; Cain Opening MC; Ramsay
`Depo Ex. 11
`
`DEX 145653
`
`Au, F, H, P, R
`
`1/1/2008 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145767
`[145773]
`
`Au, F, H, P, R
`
`1/1/2007
`
`Ramsay Rebuttal MC; Linhardt
`Rebuttal MC; Yaman Opening MC;
`Cain Opening MC
`
`DEX 145654
`[145660]
`
`Au, F, H, P, R
`
`1/1/2010 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145774
`[145781]
`
`Au, F, H, P, R
`
`Page 13 of 50
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 16 of 52 PageID #: 1367
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`DTX
`
`PTX
`
`JTX
`
`description
`
`date
`
`source
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`Yuen, V., et al., A randomised
`comparison of two intranasal
`dexmedetomidine doses for
`premedication in children, Anaesthesia,
`Vol. 67, No. 11, 1210-1216 (2012)
`
`Zhang, W., et al., Comparison of rescue
`techniques for failed chloral hydrate
`sedation for magnetic resonance imaging
`scans—additional chloral hydrate vs
`intranasal dexmedetomidine, Pediatric
`Anesthesia, Vol. 26, 273-279 (2016)
`
`Zub, D., et al., Preliminary experience
`with oral dexmedetomidine for
`procedural and anesthetic
`premedication, Pediatric Anesthesia,
`Vol. 15, 932-938 (2005)
`
`Amneal's Module 3-2-P-5-1 - Finished
`Product Spec (DEX 84084-84092)
`
`Cain Opening Expert Report On
`Invalidity Materials Considered (MC)
`
`Amneal's Module 3-2-P-8-3 - Stability
`Report (DEX 84093-84112)
`
`Barr, J, Clinical practice guidelines for
`the management of pain, agitation, and
`delirium in adult patients in the
`intensive care unit, Crit. Care Med., Vol.
`41., No. 1, 263-306 (2013)
`
`DTX081
`
`DTX082
`
`DTX083
`
`DTX084 PTX120 JTX076
`
`DTX085
`
`DTX086 PTX092 JTX056
`
`DTX087 PTX056 JTX042
`
`1/1/2012 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145782
`[145788]
`
`Au, F, H, P, R
`
`1/1/2016 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145789
`[145795]
`
`Au, F, H, P, R
`
`1/1/2005 Ramsay Rebuttal MC; Cain Opening
`MC
`
`DEX 145796
`[145802]
`
`Au, F, H, P, R
`
`1/1/2016
`
`Ramsay Opening Exs.; Linhardt
`Reply MC; Linhardt Opening Exs.;
`Cain Rebuttal MC; Bloch Rebuttal
`MC
`2/17/2017 Cain Opening MC
`Ramsay Opening Exs.; Linhardt
`Reply MC; Linhardt Opening Exs.;
`Cain Rebuttal MC; Linhardt Depo Ex.
`15; Bloch Rebuttal MC; Bloch Depo
`Ex. 2
`
`1/1/2016
`
`DEX 084084
`[84092]
`
`DEX 084093
`[84112]
`
`F, H, P, R, U
`
`1/1/2013 Ramsay Opening Exs.; Cain Rebuttal
`MC
`
`HOSPIRA 0610077
`[610120]
`
`Au, F, H, P, R
`
`Page 14 of 50
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 17 of 52 PageID #: 1368
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`DTX
`
`PTX
`
`JTX
`
`description
`
`DTX088
`
`DTX089 PTX067 JTX043
`
`DTX090 PTX068 JTX044
`
`DTX091 PTX205 JTX100
`
`DTX092
`
`DTX093 PTX119 JTX075
`
`DTX094
`
`DTX095
`
`DTX096
`
`Mani, Narasimhan - Final Transcript
`
`Precedex Product Information Sheet (4-
`2004) (HOSPIRA 1871813-1871823)
`
`Riker, Dexmedetomidine vs Midazolam
`for Sedation of Critically Ill Patients: A
`Randomized Trial, Journal of the
`American Medical Association Vol.
`301, No. 5 489-99 (2009)
`
`Defendant Amneal Pharmaceuticals
`LLC's Responses to Plaintiff's First Set
`of Interrogatories (Nos. 1-9)
`
`Bloch Rebuttal Expert Report
`
`Harvey - Chemical Kinetics (2016)
`(HOSPIRA 2498696-2498725)
`
`Hospira Scientific Report - Study PRD-
`414-06-R0 for Precedex - Justification
`for Addition of Headspace Nitrogent to
`Precedex Injection (10-2006)
`(HOSPIRA 1846480-1846483)
`
`Hospira's Module 3-2-P-2-2-1 - Drug
`Product, Formulation Development
`(HOSPIRA 1247-1248)
`
`Hospira's Module 3-2-P-5-3 - Validation
`of Analytical Producedures,
`Determination of Dexmedetomidine in
`Precedex Injection (HOSPIRA 1591-
`1597)
`
`source
`date
`11/18/2016 Ramsay Opening Exs.; Cain Rebuttal
`MC
`4/1/2004 Ramsay Opening Exs.; Cain Rebuttal
`MC
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`P, R
`
`P, R
`
`HOSPIRA 1871813
`[1871823]
`
`2/4/2009 Ramsay Opening Exs.; Cain Rebuttal
`MC
`
`HOSPIRA 0700406
`[700416]
`
`Au, F, H, P, R
`
`6/9/2016 Linhardt Reply MC
`
`3/20/2017 Linhardt Reply MC; Bloch Depo Ex.
`1
`
`1/1/2016 Linhardt Reply MC
`
`10/1/2006
`
`Linhardt Reply MC; Linhardt
`Opening Exs.; Cain Rebuttal MC;
`Linhardt Rebuttal MC; Bloch
`Rebuttal MC
`
`H, R, NE
`
`H, R
`
`HOSPIRA 2498696
`[2498725]
`
`HOSPIRA 1846480
`[1846483]
`
`F
`
`Linhardt Reply MC; Linhardt
`Rebuttal MC; Linhardt Opening Exs.;
`Cain Rebuttal MC; Yaman Reply
`MC; Linhardt Depo Ex. 7; Bloch
`Rebuttal MC
`
`Linhardt Reply MC; Linhardt
`Rebuttal MC; Linhardt Opening Exs.;
`Cain Rebuttal MC; Linhardt Depo Ex.
`9; Bloch Rebuttal MC
`
`HOSPIRA 0001247
`[1248]
`
`F
`
`HOSPIRA 0001591
`[1597]
`
`F
`
`Page 15 of 50
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 18 of 52 PageID #: 1369
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`DTX
`
`PTX
`
`JTX
`
`description
`
`date
`
`source
`Linhardt Reply MC; Linhardt
`Rebuttal MC; Linhardt Opening Exs.;
`Cain Rebuttal MC; Linhardt Depo Ex.
`8; Bloch Rebuttal MC
`Linhardt Reply MC; Linhardt
`Opening Exs.; Cain Rebuttal MC;
`Bloch Rebuttal MC
`
`1/1/2006 Linhardt Reply MC
`
`1/1/1991 Linhardt Reply MC
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`HOSPIRA 0001645
`[1646]
`
`HOSPIRA 0002222
`[2228]
`
`F
`
`F
`
`HOSPIRA 2498726
`[2498732]
`
`HOSPIRA 2498733
`[2498740]
`
`DTX097
`
`DTX098
`
`DTX099 PTX116 JTX073
`
`DTX100 PTX118 JTX74
`
`DTX101
`
`DTX102 PTX097 JTX060
`
`DTX103 PTX125 JTX079
`
`DTX104
`
`DTX105
`
`Hospira's Module 3-2-P-5-5 -
`Characterization of Impurities
`(HOSPIRA 1645-1646)
`
`Hospira's Module 3-2-S-3-2 - Impurities
`(HOSPIRA 2222-2228)
`
`K. Kumar, Linear and non-linear
`regression analysis for the sorption
`kinetics of methylene blue onto
`activated carbon, J. Haz. Mats. pp. 1538-
`44 (Apr. 2006)
`
`Matthews - Photooxidative Degradation
`of Coloured Organics in Water (1991)
`(HOSPIRA 2498733-2498740)
`
`Anes, Use of Plastics for Parenteral
`Packaging (HOSPIRA 2498613-
`2498670)
`Avis, K., Parenteral Preparations, ch. 84
`of Remington’s Pharmaceutical
`Sciences, 16th ed., pg. 1469 (1980)
`Avis, K. (ed.), Pharmaceutical Dosage
`Forms: Parenteral Medications, Volume
`1, 2nd ed., 161
`
`Bhalla, S., Parenteral Drug Delivery, ch.
`8 of Gibaldi's Drug Delivery Systems in
`Pharmaceutical Care, 103-122
`
`Ramsay Opening Infringement Expert
`Report
`
`2/17/2017
`
`Linhardt Reply MC; Linhardt
`Opening Exs.; Ramsay Depo Ex. 3;
`Yaman Reply MC; Cain Rebuttal
`MC; Bloch Rebuttal MC
`
`H, K, S
`
`Z, R
`
`Z, R, X
`
`Linhardt Rebuttal MC; Hofmann
`Reply MC; Linhardt Depo Ex. 11
`
`HOSPIRA 2498613
`[2498670]
`
`1/1/1980 Linhardt Rebuttal MC; Yaman
`Opening MC
`
`DEX 145424
`[145448]
`
`1/1/1992 Linhardt Rebuttal MC; Yaman Reply
`MC; Yaman Opening MC
`
`DEX 145449
`[145486]
`
`Linhardt Rebuttal MC; Yaman
`Opening MC
`
`DEX 145487
`[145506]
`
`Z, X
`
`Page 16 of 50
`
`

`

`Case 1:15-cv-00697-RGA Document 99-2 Filed 08/14/17 Page 19 of 52 PageID #: 1370
`Hospira, Inc. v. Amneal Pharmaceuticals LLC, C.A. No. 15-697-RGA (D. Del.)
`Amneal's Trial Exhibit List
`
`DTX
`
`PTX
`
`JTX
`
`description
`
`date
`
`source
`
`begBates
`[endBates]
`
`Hospira's
`Objections
`
`DTX106 PTX094 JTX057
`
`DTX107 PTX098 JTX061
`
`DTX108
`
`